✦ LIBER ✦

Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells

✍ Scribed by Dominique Kaiserlian; Karine Vidal; Jean-Pierre Revillard

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 494 KB
Volume: 19
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.1830190827

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vesicles bearing MHC class II molecules

Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells

✍ Paula Y. Arnold; Mark D. Mannie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 2 views

CD23/CD21 interaction is required for pr

CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones

✍ Isabelle Grosjean; Alain Lachaux; Chantal Bella; Jean-Pierre Aubry; Jean-Yves Bo 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Attenuated Listeria monocytogenescarrier

Attenuated Listeria monocytogenescarrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells

✍ Carlos A. Guzmán; Daniele Saverino; Eva Medina; Daniela Fenoglio; Birgit Gerstel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Evidence that HLA class II-restricted hu

Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms

✍ Hiroshi Fujita; Satoru Senju; Hiroshi Yokomizo; Hideyuki Saya; Michio Ogawa; Sho 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Malignant glioma cells use MHC class II

Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-γ-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T-cell activation

✍ Jeanne M. Soos; Jeffrey I. Krieger; Olaf Stüve; Chelsea L. King; Juan Carlos Pat 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

## Abstract Malignant gliomas (MGs), lethal human central nervous system (CNS) neoplasms, contain tumor infiltrating lymphocytes (TIL). Although MHC class II molecules are frequently detected on MG cells, suggesting that they may be capable of antigen (Ag) presentation to CD4^+^ T cells, deficienci

Peptide-antibody conjugates for tumour t

Peptide-antibody conjugates for tumour therapy: A MHC-class-II-restricted tetanus toxin peptide coupled to an anti-IG light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells

✍ Zhiwei Yu; Frank Healy; Danila Valmori; Patricia Escobar; Giampietro Corradin; J 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 729 KB

Anti-idiotype antibody therapy of B-cell lymphomas, despite numerous promising experimental and clinical studies, has so far met with limited success. Tailor-made monoclonal antiidiotype antibodies have been injected into a large series of lymphoma patients, with a few impressive complete tumour rem